GLP-1 receptor agonists have transformed the treatment of obesity and weight management, helping millions of people lose weight through medically supervised treatment.

But how do they actually work?

Unlike traditional diets that rely on willpower alone, GLP-1 receptor agonists work by mimicking one of your body's natural hormones, helping regulate hunger, appetite and blood sugar levels.

In this guide, we'll explain exactly how GLP-1 receptor agonists work, why they're effective for weight management, and how Cannaray Wellness helps eligible patients access these treatments safely.

What is GLP-1?

GLP-1 stands for Glucagon-Like Peptide-1.

It is a hormone naturally produced in your small intestine after you eat.

Its role is to help your body manage food intake by communicating with several organs, including:

• Your brain
• Your stomach
• Your pancreas
• Your digestive system

Together, these signals help regulate hunger, blood sugar and feelings of fullness.

What is a GLP-1 receptor agonist?

A GLP-1 receptor agonist is a medication that mimics the action of your body's natural GLP-1 hormone.

Rather than replacing the hormone completely, these medicines activate GLP-1 receptors throughout the body, producing similar biological effects that can support weight management.

Examples include:

• Wegovy (semaglutide)
• Mounjaro (tirzepatide)*
• Wegovy tablet (oral semaglutide)

*Although Mounjaro also activates GIP receptors, it still stimulates the GLP-1 receptor and is commonly included in discussions about GLP-1-based treatments.

How GLP-1 receptor agonists work

Once administered, GLP-1 receptor agonists begin interacting with receptors found throughout the body.

They don't simply "burn fat."

Instead, they influence several systems that affect how much you eat and how your body processes food.

Let's look at each effect.

1. They reduce appetite

One of the biggest reasons GLP-1 medications are effective is their effect on appetite.

They send signals to appetite-regulating areas of the brain, helping you feel less hungry throughout the day.

Many patients report:

• Feeling hungry less often
• Smaller portion sizes
• Less desire to snack
• Reduced food cravings

Rather than constantly thinking about food, many people describe feeling satisfied after eating much smaller meals.

2. They help you feel fuller for longer

GLP-1 receptor agonists also increase feelings of satiety, the sensation of being full after eating.

This means meals tend to keep you satisfied for longer, making it easier to maintain a calorie deficit without feeling deprived.

3. They slow stomach emptying

Another important effect is slowing the rate at which food leaves the stomach.

This process, known as delayed gastric emptying, means:

• Food remains in the stomach for longer.
• Fullness lasts longer after meals.
• Hunger returns more gradually.

For many people, this contributes significantly to reduced calorie intake.

Because stomach emptying is slower, some people may experience gastrointestinal side effects, particularly during the first few weeks of treatment, which is why doses are usually increased gradually under medical supervision.

4. They improve blood sugar regulation

GLP-1 receptor agonists were originally developed to help manage type 2 diabetes.

They support healthy blood sugar regulation by:

• Stimulating insulin release when blood glucose rises.
• Reducing glucagon production, a hormone that raises blood sugar.
• Helping the body respond more effectively after meals.

These effects occur in a glucose-dependent way, meaning insulin release increases mainly when blood sugar levels are elevated.

5. They make it easier to maintain a calorie deficit

Weight loss ultimately happens when you consume fewer calories than your body uses.

GLP-1 receptor agonists help make this easier by combining several effects:

• Reduced hunger
• Longer-lasting fullness
• Fewer cravings
• Smaller meal sizes

For many people, these changes make healthier eating patterns feel more manageable over time.

How is Mounjaro different?

While both Wegovy and Mounjaro act on GLP-1 receptors, Mounjaro also targets another hormone called GIP (Glucose-Dependent Insulinotropic Polypeptide).

Because it activates both GLP-1 and GIP receptors, Mounjaro is often referred to as a dual GIP/GLP-1 receptor agonist.

Researchers believe this dual action may contribute to greater average weight loss in some patients compared with GLP-1-only treatments, although the most suitable medication depends on individual clinical circumstances.

How long does it take to work?

Although everyone responds differently, many people begin noticing changes in appetite within the first few weeks.

Weight loss itself is usually gradual and depends on several factors, including:

• Diet
• Physical activity
• Dose adjustments
• Adherence to treatment
• Individual metabolism

GLP-1 medications are designed to support long-term weight management rather than rapid short-term weight loss.

Why lifestyle changes still matter

GLP-1 receptor agonists are most effective when combined with healthy lifestyle habits.

Healthcare professionals recommend:

• Eating a balanced diet
• Staying physically active
• Drinking enough water
• Prioritising sleep
• Attending regular clinical reviews

Medication works best as one part of a broader weight management plan.